Related Experiment Video
Updated: Aug 4, 2025

Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks
Published on: December 2, 2022
Antimycotic effect of 3-phenyllactic acid produced by probiotic bacterial isolates against Covid-19 associated
Ravikumar Lunavath1, Saddam Hussain Mohammad1, Kiran Kumar Bhukya1
1Centre for Microbial and Fermentation Technology, Department of Microbiology, University College of Science, Osmania University, Hyderabad, India.
Abstract:
The Covid-19 associated mucormycosis (CAM) is an emerging disease affecting immunocompromised patients. Prevention of such infections using probiotics and their metabolites persist as effective therapeutic agents. Therefore, the present study emphasizes on assessment of their efficacy and safety. Samples from different sources like human milk, honey bee intestine, toddy, and dairy milk were collected, screened and characterized for potential probiotic lactic acid bacteria (LAB) and their metabolites to be used as effective antimicrobial agents to curtail CAM. Three isolates were selected based on probiotic properties and characterized as Lactobacillus pentosus BMOBR013, Lactobacillus pentosus BMOBR061 and Pediococcus acidilactici BMOBR041 by 16S rRNA sequencing and MALDI TOF-MS. The antimicrobial activity against standard bacterial pathogens showed ˃9 mm zone of inhibition. Furthermore, the antifungal activity of three isolates was tested against Aspergillus flavus MTCC 2788, Fusarium oxysporum, Candida albicans and Candida tropicalis where the results showed significant inhibition of each fungal strain. Further studies were carried out on lethal fungal pathogens like Rhizopus sp. and two Mucor sp. which are associated with post Covid-19 infection in immunosuppressed diabetic patients. Our studies on CAM inhibitory effect of LAB revealed the efficient inhibition against Rhizopus sp. and two Mucor sp. The cell free supernatants of three LAB showed varied inhibitory activity against these fungi. Following the antimicrobial activity, the antagonistic metabolite 3-Phenyllactic acid (PLA) in culture supernatant was quantified and characterized by HPLC and LC-MS using standard PLA (Sigma Aldrich). The isolate L. pentosus BMOBR013 produced highest PLA (0.441 g/L), followed by P. acidilactici BMOBR041 (0.294 g/L) and L. pentosus BMOBR061 (0.165 g/L). The minimum inhibitory concentration of HPLC eluted PLA on the Rhizopus sp. and two Mucor sp. was found to be 180 mg/ml which was further confirmed by inhibition of total mycelia under live cell imaging microscope.
Insights
Probiotic lactic acid bacteria (LAB) and their metabolite 3-phenyllactic acid show significant antifungal activity against Covid-19 associated mucormycosis (CAM) pathogens. This research highlights potential new strategies for preventing and treating CAM in immunocompromised patients.
Area of Science:
- Microbiology
- Immunology
- Biochemistry
Background:
- Covid-19 associated mucormycosis (CAM) is an emerging threat to immunocompromised individuals.
- Probiotics and their metabolites offer a promising avenue for preventing and treating opportunistic fungal infections like CAM.
Purpose of the Study:
- To assess the efficacy and safety of probiotic lactic acid bacteria (LAB) and their metabolites against CAM pathogens.
- To identify and characterize LAB with antimicrobial and antifungal properties from various natural sources.
Main Methods:
- Isolation and characterization of LAB from human milk, honey bee intestine, toddy, and dairy milk using 16S rRNA sequencing and MALDI TOF-MS.
- Antimicrobial and antifungal activity assays against standard and pathogenic fungi, including Rhizopus sp. and Mucor sp.
- Quantification and characterization of the antagonistic metabolite 3-phenyllactic acid (PLA) using HPLC and LC-MS.
Main Results:
- Three LAB isolates (Lactobacillus pentosus BMOBR013, Lactobacillus pentosus BMOBR061, Pediococcus acidilactici BMOBR041) exhibited significant antifungal activity against CAM-associated fungi.
- 3-Phenyllactic acid (PLA) was identified as the key antagonistic metabolite, with L. pentosus BMOBR013 producing the highest yield (0.441 g/L).
- The minimum inhibitory concentration of PLA against Rhizopus sp. and Mucor sp. was determined to be 180 mg/ml.
Conclusions:
- Probiotic LAB and their metabolite PLA demonstrate potent inhibitory effects against Covid-19 associated mucormycosis pathogens.
- These findings support the development of probiotic-based strategies for the prevention and treatment of CAM.
More Related Videos
Related Concept Videos
Fungal Group Zygomycota
Antimicrobial Effectiveness
Fungal Phylum Microsporidia

